Job Description

Building trusted partnerships is an essential way we work together to deliver meaningful impact to patients’ lives. The Market Access function is a strategic and multidisciplinary role dedicated to enabling our innovative medical technologies to be accessible, reimbursable, and adopted by healthcare providers. Your work will not simply focus on improving access; together with talented team members, you'll contribute to better health outcomes for patients across the globe.

The Senior Market Access Manager, Health Economics and Reimbursement, plays a pivotal role in ensuring our Structural Heart Therapies are recognized for their economic and clinical value by health technology assessment (HTA) bodies in Australia and New Zealand. This position exists to drive technical submissions, working closely with the head of market access and government affairs, to enhance market access for life-saving therapies.

How you will make an impact:

• Expertise in Australian Health Technology Assessment (HTA) System: Maintain deep knowledge and understanding of the HTA landscape, including processes, guidelines, and requirements in Australia and New Zealand, ensuring our team is aligned with current and emerging policies.
• Planning, Preparing, and Executing Reimbursement Applications: Develop and manage technical submissions for the Medical Services Advisory Committee (MSAC), Medical Devices and Human Tissue Advisory Committee, and other relevant HTA bodies in ANZ. This includes creating comprehensive, high-quality reimbursement applications that meet HTA standards and criteria.
• Strategic Development and Market Access Gap Identification: Formulate proactive strategies to enhance market access by identifying and addressing clinical, economic, data, and policy gaps. Anticipate potential access barriers and implement plans to mitigate cost containment risks for future reimbursement applications.
• Health Economics Expertise for Stakeholders: Serve as an expert resource on the health economics of Edwards’ Structural Heart Therapies, providing insights to key opinion leaders (KOLs), medical societies, private insurers, industry associations (e.g., MTAA, MTANZ), academia, and external advisors.
• Economic Value Communication: Communicate the economic and clinical value of Edwards’ products to government agencies, physicians, and other healthcare stakeholders, ensuring a clear understanding of how our therapies contribute to patient outcomes and healthcare system efficiency.
• Strategic Relationship Building and Cross-Functional Support: Build and nurture strategic relationships within Edwards, supporting cross-functional teams, including sales, marketing, government affairs, regulatory, medical/clinical affairs, and patient engagement, to ensure market access goals are integrated into broader business objectives
• Global and Regional Collaboration: Actively collaborate with country senior staff, market access peers, and global Edwards teams to align on strategies, share insights, and leverage best practices for optimized access outcomes in the region.
• Private Market Payor and KOL Advisory Boards: Organize and conduct advisory boards with private payors and KOLs, as needed, to gather insights, assess market needs, and refine strategies for improving market access
• Advocacy Engagement: Represent Edwards in partnerships with patient and consumer advocacy organizations, working closely with the Government Affairs lead to ensure the patient perspective is reflected in the value proposition of our therapies.
• Other Incidental Duties: Perform additional tasks as required to support the public affairs function and advance the organization’s mission

What you’ll need (Required):

• Bachelor’s degree in a life science, Biomedical, Science, Public Health, health economics, health policy, or related field with minimum of 12 years of experience. E.g., Experience in health policy, health economics, medical device reimbursement and technology assessment in Australia. Or Master’s degree in a life science, health economics, health policy, or related field.
• Minimum of 10 years of HTA experience across medical technology, pharmaceutical and or biomedical.
• Understanding of medical and clinical research methods (e.g. Markov modelling and or Monte Carlo simulation) and publication interpretation with ability to use evidence to support value proposition.
• Strong business and clinical acumen, analytical skills, and experience working with various internal business partners (especially Sales, Marketing, Clinical, Regulatory, Legal, and Government Affairs staff) to provide insight into key economic and reimbursement issues.
• Knowledge mastery of health economics and local healthcare market, insurance landscape, relevant reimbursement processes, and or the ability to quickly understand different therapeutic areas.
• Participated to publication process/RWE/data generation projects.
• Ability to build and maintain strong relationships with HTA bodies and physicians.
• Ability to manage multiple projects across different therapeutic areas and work well under stress (timelines).
• A team player, self-motivated, result oriented, problem solver with strong ownership and leadership skills.
• Strong communication and influencing skills, able to work in a matrix environment and to effectively communicate with hospital administrators (assist with C-Suite level engagement) and collaborate with other field-based reps to deliver economic messaging to clinicians.
• Proficient in Microsoft Office Suite (i.e., Excel, PowerPoint, Word, Outlook).
• Excellent interpersonal skills, written and verbal communication skills, especially presentation development and delivery.
• Expert understanding of related aspects of health economics & reimbursement processes
• Strict attention to detail
• Ability to interact professionally with all organizational levels and proactively escalate issues to appropriate levels of management in the organization.
• Ability to manage competing priorities in a fast-paced environment
• Availability to travel within ANZ about 20-25% of the time and 5-10% of the time internationally